An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease.
about
An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An updated systematic review a ...... severe chronic kidney disease.
@en
An updated systematic review a ...... severe chronic kidney disease.
@nl
type
label
An updated systematic review a ...... severe chronic kidney disease.
@en
An updated systematic review a ...... severe chronic kidney disease.
@nl
prefLabel
An updated systematic review a ...... severe chronic kidney disease.
@en
An updated systematic review a ...... severe chronic kidney disease.
@nl
P2860
P356
P1433
P1476
An updated systematic review a ...... severe chronic kidney disease
@en
P2093
Catherine Harrington
Devada Singh-Franco
P2860
P304
2050312116659090
P356
10.1177/2050312116659090
P577
2016-07-28T00:00:00Z